It’s not surprising that last week Haruko Obokata issued a plea for privacy. On Jan. 29 she published a scientific paper on stem cells that could revolutionize medicine, and overnight the researcher based at the Riken Center for Developmental Biology (CDB) in Kobe became a domestic and international star.

The onslaught of media attention went beyond what Obokata had discovered — a way to revert ordinary cells from the body into kansaibō (stem cells), cells with the ability to develop into any cell type. These cells, known as pluripotent stem cells, have long been seen as the key to regenerative medicine, because in theory they can be grown into new organs and tissues.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.